In 2016, Tan reported the case of a young man with a metastatic AM, treated with ipilimumab, who showed improvement of 5 months, until the patient showed signs of disease progression 64 ardomon 50 mg 4 for the two arms, respectively P 0
In 2016, Tan reported the case of a young man with a metastatic AM, treated with ipilimumab, who showed improvement of 5 months, until the patient showed signs of disease progression 64 ardomon 50 mg 4 for the two arms, respectively P 0